Measure # Weight Measure Description Points
Collaborative Meeting Participation: ASPIRE Quality Champion and
Anesthesiology Clinical Quality Reviewer (ACQR) combined attendance at
meetings. Three total meetings with six opportunities for attendance.
6 / 6 Meetings
10
5 / 6 Meetings
5
4 or Less Meetings
0
Attend ASPIRE Quality Committee e-meetings: ASPIRE Quality Champion or
ACQR attendance across six meetings.
5 - 6 / 6 Meetings
5
4 or less Meetings
0
ACQR/ASPIRE Quality Champion perform data validation, case validation and
submit data by the 3rd Wednesday of each month for January - November
and by the 2nd Wednesday of the month for December. Data must be of
high quality upon submission, >90% of diagnostics marked as ‘Data
Accurately Represented.’
10 - 12/12 Months
5
9 or Less Months
0
Site Based Quality Meetings: Sites to hold an onsite in-person or virtual
meeting following the three ASPIRE Collaborative meetings to discuss the
data and plans for quality improvement at their site.
3 Meetings 10
2 Meetings 5
1 Meeting 0
Sustainabilty (SUS 02) Percentage of cases where carbon dioxide equivalents
(CO2 eq) normalized by hour for cases receiving halogenated agents and/or
nitrous oxide is less than CO2 eq of 2% sevoflurane at 2L FGF = 2.83 kg
CO2/hr during the maintenance period of anesthesia OR the Total CO2e is
less than 2.83 kg CO2.
(cumulative score January 1, 2024 ‐ December 31, 2024)
Performance is ≥ 45% or show improvement of 10 percentage points 25
Performance is ≥ 40% 15
Performance is ≥ 35% 10
Performance is < 35% 0
Postoperative Nausea and Vomiting (PONV 05) Percentage of patients who
had a procedure requiring general anesthesia or cesarean delivery and
administered appropriate prophylaxis for PONV.
(cumulative score January 1, 2024 ‐ December 31, 2024)
Performance is ≥ 70% or improvement of 15 percentage points 20
Performance is ≥ 65% 15
Performance is ≥ 60% 10
Performance is < 60% 0
Site Directed Measure: Sites choose a measure they are performing
above/below ASPIRE threshold or needs improvement by December 8, 2023.
(cumulative score January 1, 2024 through December 31, 2024)
Performance is ≥90%; ≤10%; ≤5% or show ≥15% improvement (absolute) 25
Performance is ≥85%; ≤15%; ≤10% or show ≥10% improvement (absolute) 15
Performance is ≥80%; ≤20%; ≤15% or show ≥5% improvement (absolute) 10
Performance is <80%; >20%; >15% or show <5% improvement (absolute) 0
6
20%
5
25%
4
10%
7
25%
3
5%
2024 Anesthesiology Quality Improvement and Reporting Exchange (ASPIRE)
Collaborative Quality Initiative Performance Index Scorecard
Cohorts 1 - 7
Measurement Period: 01/01/2024 - 12/31/2024
2
5%
1
10%
Anesthesiology Performance Improvement and Reporting Exchange (ASPIRE)
2024 Performance Index Scorecard
Measure Explanation: Cohorts 1 7 (2015 2022 start)
Measure #1: The ASPIRE Quality Champion (or a designated representative who must be an
anesthesiologist) and the Anesthesiology Clinical Quality Reviewer (ACQR), combined, must attend
ASPIRE Collaborative meetings in 2024. There are three total meetings with six opportunities for
attendance:
1. MSQC (Michigan Surgical Quality Collaborative) / ASPIRE Meeting: Friday, April 12, 2024
2. ASPIRE Collaborative Meeting: Friday, July 12, 2024
3. MPOG (Multicenter Perioperative Outcomes Group) Retreat: Friday, October 18, 2024
Measure #2: There will be six Quality Committee e-meetings in 2024. One representative (ASPIRE
Quality Champion or ACQR) must attend the following 2024 meetings:
1. Monday, January 22, 2024
2. Monday, February 26, 2024
3. Monday, May 20, 2024
4. Monday, July 22, 2024
5. Monday, September 23, 2024
6. Monday, November 25, 2024
Measure #3: Maintenance Schedule located on MPOG website in the resources tab of the quality
section. Data must be of high quality upon submission, >90% of diagnostics marked as ‘Data Accurately
Represented.’
Measure #4: The site is expected to schedule a local meeting either in-person or virtually following each
ASPIRE collaborative meeting (see Measure #1 for dates) to discuss site-based and collaborative quality
outcomes with clinical providers at their site. Sites must send the coordinating center the site-based
collaborative meeting report located on the MPOG website in the P4P sub tab of the Michigan hospitals
tab of the quality section.
Measure #5: Sites will be awarded points for compliance with the sustainability measure SUS 02
(cumulative score January 1, 2024, through December 31, 2024). If the performance threshold is not
met, Coordinating Center will assess initial 12-month average score for January December 2023 and
compare to 12-month average score for January December 2024. Absolute percentage point
improvement will be evaluated to allocate points. See P4P Scorecard for point distribution.
Measure #6: Sites will be awarded points for compliance with the postoperative nausea and vomiting
PONV 05 (cumulative score January 1, 2024, through December 31, 2024). If the performance threshold
is not met, Coordinating Center will assess initial 12-month average score for January December 2023
and compare to 12-month average score for January December 2024. Absolute percentage point
improvement will be evaluated to allocate points. See P4P Scorecard for point distribution.
Measure #7: Sites will choose a measure where performance is above the ASPIRE threshold for inverse
(outcome) measures (5 or 10%) or a process measure with performance less than threshold (90%) that needs
improvement. Sites must submit their current measure score (November 1, 2022 through October 31, 2023)
to the Coordinating Center by Friday, December 8, 2023, for review and approval. Measure selection form is
located on the MPOG website in the P4P sub tab of the Michigan hospitals tab of the quality section. If the
performance threshold is not met, ASPIRE Coordinating Center will assess initial 12-month average score
for November October 2023 and compare to 12-month average score for January December 2024.
Absolute percentage point improvement will be evaluated to allocate points. See P4P Scorecard for point
distribution.